Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice

Atherosclerosis

Volumn 155, Issue 2, 2001, Pages 291-295

  Arnal, J F ^a   Castano, C ^a   Maupas, E ^a   Mugniot, A ^a   Darblade, B ^a   Gourdy, P ^a   Michel, J B ^b   Bayard, F ^a  

^a CHU RANGUEIL   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Angiotensin converting enzyme; Apolipoprotein E deficient mice; Fatty streak; Neutral endopeptidase

Indexed keywords

APOLIPOPROTEIN E; CANDOXATRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALINASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OMAPATRILAT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERLIPOPROTEINEMIA TYPE 3; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ATRIAL NATRIURETIC FACTOR; BODY WEIGHT; BRADYKININ; CHOLESTEROL; CHOLESTEROL, HDL; DRUG EVALUATION, PRECLINICAL; INDANS; MALE; MICE; MICE, KNOCKOUT; NEPRILYSIN; PROPIONATES; PROTEASE INHIBITORS; PYRIDINES; SUBSTANCE P; THIAZEPINES; TRIGLYCERIDES;

EID: 0035092420     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00565-7     Document Type: Article

References (31)

1. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology
2. Endothelium-derived relaxing and contracting factors
3. Supression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11)
4. Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit
5. Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits
6. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
7. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
8. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
9. Atherosclerosis in mice lacking apoE - Evaluation of lesional development and progression
10. Gene targeting approaches to complex genetic diseases: Atherosclerosis and essential hypertension
11. Vacular biology in genetically altered mice. Smaller vessels, bigger insight
12. Antiatherosclerotic and antioxidative effects of ACE inhibitors in apolipoprotein E-deficient mice
13. Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice
14. The angiotensin-II receptor antagonist, losartan, inhibits lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice
15. State-of-art lecture. Statins and blockers of the renin-angiotensin system: Vascular protection beyond their primary mode of action
16. Tissue-specific expression of the human gene for lecithin: Cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile
17. Quantitative assesment of atherosclerotic lesions in mice
18. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta
19. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits
20. The prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice
21. Nitric oxide regulation of tissue free radical injury
22. Assessment of factors important in atherosclerotic occlusion and restenosis
23. Effects of different natriuretic peptides in nitric oxide synthesis in macrophages
24. Atrial natriuretic peptide inhibits nitric oxide synthesis in mouse macrophages
25. Effects of atrial natriuretic peptide on phagocytosis and respiratory burst in murine macrophages
26. Expression and differential regulation of natriuretic peptide in mouse macrophages
27. Angiotensin II-stimulated NO and peroxynitrite production in endothelial cells
28. Endothelial VCAM-1 is stimulated by angiotensin II through induction of mitochondrial-generated oxidative stress
29. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation
30. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature
31. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway